Paper39974366
Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients.
Vodă IM and 10 others. Front Neurol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients. Papers, record 39974366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39974366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ocrelizumab-induced colitis-critical review and case series from a Romanian cohort of MS patients.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36736346 | Ocrelizumab-induced colitis and cytomegalovirus infection and their disadvantageous interaction with underlying multiple sclerosis. | Z Gastroenterol | 2023 | https://conductscience.org/library/papers/36736346 | PubMed |
| 2 | 30171504 | Ocrelizumab: A Review in Multiple Sclerosis. | CNS Drugs | 2018 | https://conductscience.org/library/papers/30171504 | PubMed |
| 3 | 33948072 | Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis. | Ann Gastroenterol | 2021 | https://conductscience.org/library/papers/33948072 | PubMed |
| 4 | 30905719 | De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center. | Clin Gastroenterol Hepatol | 2020 | https://conductscience.org/library/papers/30905719 | PubMed |
| 5 | 30410033 | Multiple sclerosis. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/30410033 | PubMed |
| 6 | 34513436 | A Review of Four Practice Guidelines of Inflammatory Bowel Disease. | Cureus | 2021 | https://conductscience.org/library/papers/34513436 | PubMed |
| 7 | 21098319 | Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21098319 | PubMed |
| 8 | 22796801 | Biologic therapies: lessons from multiple sclerosis. | Dig Dis | 2012 | https://conductscience.org/library/papers/22796801 | PubMed |
| 9 | 31945371 | AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31945371 | PubMed |
| 10 | 32198886 | First Case of Refractory Colitis Caused by Ocrelizumab. | Inflamm Bowel Dis | 2020 | https://conductscience.org/library/papers/32198886 | PubMed |
| 11 | 31753762 | The gut microbiome in neurological disorders. | Lancet Neurol | 2020 | https://conductscience.org/library/papers/31753762 | PubMed |
| 12 | 33642561 | Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review. | Intern Med | 2021 | https://conductscience.org/library/papers/33642561 | PubMed |
| 13 | 27934854 | Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. | Nat Rev Neurol | 2017 | https://conductscience.org/library/papers/27934854 | PubMed |
| 14 | 38114289 | Histologic manifestations of ocrelizumab-associated intestinal and hepatic injury in patients with multiple sclerosis. | Histopathology | 2024 | https://conductscience.org/library/papers/38114289 | PubMed |
| 15 | 38344628 | Two Cases of Acute Diverticulitis Following Ocrelizumab Infusion in Patients With Multiple Sclerosis. | Cureus | 2024 | https://conductscience.org/library/papers/38344628 | PubMed |
| 16 | 37706452 | Colitis in ocrelizumab-treated patients: The dilemma of causation versus association in immune-mediated iatrogenicity. | Mult Scler | 2023 | https://conductscience.org/library/papers/37706452 | PubMed |
| 17 | 31392849 | Environmental and genetic risk factors for MS: an integrated review. | Ann Clin Transl Neurol | 2019 | https://conductscience.org/library/papers/31392849 | PubMed |
| 18 | 29358322 | B-Cell Therapies in Multiple Sclerosis. | Cold Spring Harb Perspect Med | 2019 | https://conductscience.org/library/papers/29358322 | PubMed |
| 19 | 27741097 | World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. | J Clin Gastroenterol | 2016 | https://conductscience.org/library/papers/27741097 | PubMed |
| 20 | 21477588 | Cytokines and effector T cell subsets causing autoimmune CNS disease. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21477588 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943211 | Ocrelizumab-Induced Leukocyte Subpopulations Dynamics in Multiple Sclerosis. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943211 | PubMed |
| 42911175 | Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/42911175 | PubMed |
| 41693080 | Ocrelizumab-induced colitis: VigiBase disproportionality analysis, case reports and literature review. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41693080 | PubMed |
| 41317369 | Inflammatory bowel disease therapies and demyelinating diseases: a practical guide to therapeutic benefit and risk. | J Crohns Colitis | 2026 | https://conductscience.org/library/papers/41317369 | PubMed |
| 41291183 | Longstanding histological colitis following ocrelizumab therapy: a case report. | Acta Neurol Belg | 2026 | https://conductscience.org/library/papers/41291183 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39974366
GET https://conductscience.org/api/papers/v1/39974366/references?page=2